NLRP3 and rheumatoid arthritis: In addition, Pentaxin 3, which is upregulated in the plasma of patients with rheumatoid arthritis, can act synergistically with the ligand C1q to activate NLRP3 inflammasome, causing caspase-1-mediated pyroptosis and inflammatory cytokines, the degree of which was consistent with disease activity [42].